INTEC PHARMA LTD.
12 Hartom Street
Har Hotzvim, Jerusalem 9777512, Israel
(+972) (2) 586-4657
June 15, 2017
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ms. Ada D. Sarmento
Re: Intec Pharma Ltd.
Registration Statement on Form F-3
File No. 333-218539
Filed June 6, 2017
Ladies and Gentlemen:
Intec Pharma Ltd., an Israeli company (the “Company”), hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement on Form F-3 (the “Registration Statement”) so that the Registration Statement will become effective at 5:00 p.m. (Washington, DC time) on June 19, 2017, or as soon thereafter as practicable.
Please provide a copy of the Commission’s order declaring the Registration Statement effective to the undersigned at 12 Hartom Street, Har Hotzvim, Jerusalem 9777512, Israel.
Very truly yours,
INTEC PHARMA LTD.
By:/s/ Nir Sassi
Nir Sassi
Chief Financial Officer